| 发明名称 |
MODULATION OF NLGn4 EXPRESSION, NK CELL ACTIVITY IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) |
| 摘要 |
The present invention provides a method of diagnosing and/or monitoring a liver disorder in a subject. The method calls for isolating an immune cell population from a biological sample of the subject; and detecting expression level of an NLGn4 gene product in the immune cell population using NLGn4 specific primers or NLGn4 specific probes. |
| 申请公布号 |
US2016369347(A1) |
申请公布日期 |
2016.12.22 |
| 申请号 |
US201615256781 |
申请日期 |
2016.09.06 |
| 申请人 |
HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. |
发明人 |
SAFADI Rifaat |
| 分类号 |
C12Q1/68;A61K31/7088;C12N15/113 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of diagnosing and/or monitoring a liver disorder in a subject, the method comprising: isolating an immune cell population from a biological sample of the subject; detecting expression level of an NLGn4 gene product in the immune cell population using NLGn4 specific primers or NLGn4 specific probes. |
| 地址 |
JERUSALEM IL |
